Yatin Suneja
Stock Analyst
(3.19)
# 1,333
Out of 4,648 analysts
106
Total ratings
47.83%
Success rate
0.96%
Average return
Main Sectors:
Stocks Rated by Yatin Suneja
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARGX argenx SE | Maintains: Buy | $585 → $665 | $588.67 | +12.97% | 8 | Nov 1, 2024 | |
| SYRE Spyre Therapeutics | Maintains: Buy | $50 → $65 | $35.13 | +85.03% | 1 | Oct 25, 2024 | |
| ANAB AnaptysBio | Maintains: Buy | $75 → $90 | $19.94 | +351.35% | 10 | Oct 21, 2024 | |
| ZBIO Zenas BioPharma | Initiates: Buy | $45 | $19.95 | +125.56% | 1 | Oct 8, 2024 | |
| VIGL Vigil Neuroscience | Maintains: Buy | $17 → $16 | $3.87 | +313.44% | 2 | Aug 14, 2024 | |
| PRAX Praxis Precision Medicines | Maintains: Buy | $155 → $170 | $70.02 | +142.79% | 2 | Aug 14, 2024 | |
| NBIX Neurocrine Biosciences | Maintains: Buy | $170 → $180 | $120.53 | +49.34% | 3 | Aug 2, 2024 | |
| REGN Regeneron Pharmaceuticals | Maintains: Buy | $1,180 → $1,300 | $828.84 | +56.85% | 5 | Aug 2, 2024 | |
| ALMS Alumis | Initiates: Buy | $32 | $11.42 | +180.21% | 1 | Jul 23, 2024 | |
| QTTB Q32 Bio | Initiates: Buy | $100 | $46.84 | +113.49% | 1 | Jun 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.27 | - | 3 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $10.55 | +373.93% | 1 | Apr 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $90 | $25.39 | +254.47% | 5 | Feb 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $125 | $87.25 | +43.27% | 8 | Feb 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $32 | $59.50 | -46.22% | 3 | Jan 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $16 | $11.53 | +38.77% | 2 | Nov 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $70 → $77 | $46.40 | +65.95% | 3 | Nov 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $26.90 | +85.87% | 1 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $11.71 | +87.87% | 1 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $32 | $29.42 | +8.77% | 5 | Sep 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $34 | $4.00 | +750.00% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.64 | - | 3 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $4.37 | +357.67% | 1 | Jun 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $49 | $41.71 | +17.48% | 2 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $52 → $55 | $11.70 | +370.09% | 2 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $14 | $7.57 | +84.94% | 3 | May 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $270 → $350 | $173.52 | +101.71% | 3 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $1.56 | - | 4 | Apr 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $22 | $14.62 | +50.48% | 5 | Jan 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.81 | - | 5 | Jan 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $11.88 | - | 2 | Nov 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $42 → $30 | $18.94 | +58.39% | 2 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.42 | - | 3 | Oct 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $19.88 | +20.72% | 1 | May 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $29 → $34 | $38.15 | -10.88% | 2 | Jan 14, 2020 |
argenx SE
Nov 1, 2024
Maintains: Buy
Price Target: $585 → $665
Current: $588.67
Upside: +12.97%
Spyre Therapeutics
Oct 25, 2024
Maintains: Buy
Price Target: $50 → $65
Current: $35.13
Upside: +85.03%
AnaptysBio
Oct 21, 2024
Maintains: Buy
Price Target: $75 → $90
Current: $19.94
Upside: +351.35%
Zenas BioPharma
Oct 8, 2024
Initiates: Buy
Price Target: $45
Current: $19.95
Upside: +125.56%
Vigil Neuroscience
Aug 14, 2024
Maintains: Buy
Price Target: $17 → $16
Current: $3.87
Upside: +313.44%
Praxis Precision Medicines
Aug 14, 2024
Maintains: Buy
Price Target: $155 → $170
Current: $70.02
Upside: +142.79%
Neurocrine Biosciences
Aug 2, 2024
Maintains: Buy
Price Target: $170 → $180
Current: $120.53
Upside: +49.34%
Regeneron Pharmaceuticals
Aug 2, 2024
Maintains: Buy
Price Target: $1,180 → $1,300
Current: $828.84
Upside: +56.85%
Alumis
Jul 23, 2024
Initiates: Buy
Price Target: $32
Current: $11.42
Upside: +180.21%
Q32 Bio
Jun 17, 2024
Initiates: Buy
Price Target: $100
Current: $46.84
Upside: +113.49%
May 10, 2024
Downgrades: Neutral
Price Target: n/a
Current: $2.27
Upside: -
Apr 29, 2024
Initiates: Buy
Price Target: $50
Current: $10.55
Upside: +373.93%
Feb 27, 2024
Maintains: Buy
Price Target: $72 → $90
Current: $25.39
Upside: +254.47%
Feb 21, 2024
Maintains: Buy
Price Target: $110 → $125
Current: $87.25
Upside: +43.27%
Jan 2, 2024
Maintains: Buy
Price Target: $16 → $32
Current: $59.50
Upside: -46.22%
Nov 15, 2023
Maintains: Buy
Price Target: $17 → $16
Current: $11.53
Upside: +38.77%
Nov 15, 2023
Maintains: Buy
Price Target: $70 → $77
Current: $46.40
Upside: +65.95%
Oct 31, 2023
Initiates: Buy
Price Target: $50
Current: $26.90
Upside: +85.87%
Oct 10, 2023
Initiates: Buy
Price Target: $22
Current: $11.71
Upside: +87.87%
Sep 22, 2023
Reiterates: Buy
Price Target: $32
Current: $29.42
Upside: +8.77%
Aug 14, 2023
Reiterates: Buy
Price Target: $34
Current: $4.00
Upside: +750.00%
Jul 17, 2023
Downgrades: Neutral
Price Target: n/a
Current: $0.64
Upside: -
Jun 22, 2023
Initiates: Buy
Price Target: $20
Current: $4.37
Upside: +357.67%
Jun 15, 2023
Reiterates: Buy
Price Target: $49
Current: $41.71
Upside: +17.48%
May 18, 2023
Maintains: Buy
Price Target: $52 → $55
Current: $11.70
Upside: +370.09%
May 17, 2023
Maintains: Buy
Price Target: $12 → $14
Current: $7.57
Upside: +84.94%
May 1, 2023
Upgrades: Buy
Price Target: $270 → $350
Current: $173.52
Upside: +101.71%
Apr 6, 2023
Upgrades: Buy
Price Target: n/a
Current: $1.56
Upside: -
Jan 3, 2023
Upgrades: Buy
Price Target: $22
Current: $14.62
Upside: +50.48%
Jan 3, 2023
Downgrades: Neutral
Price Target: n/a
Current: $5.81
Upside: -
Nov 18, 2022
Downgrades: Neutral
Price Target: n/a
Current: $11.88
Upside: -
Nov 11, 2022
Maintains: Buy
Price Target: $42 → $30
Current: $18.94
Upside: +58.39%
Oct 14, 2022
Downgrades: Neutral
Price Target: n/a
Current: $3.42
Upside: -
May 31, 2022
Initiates: Buy
Price Target: $24
Current: $19.88
Upside: +20.72%
Jan 14, 2020
Maintains: Buy
Price Target: $29 → $34
Current: $38.15
Upside: -10.88%